Not Yet Recruiting
Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)
NCT07629206
- Conditions
- Breast Diseases, Breast Neoplasms, Low-Risk, Early Stage Breast Cancer, +4 more
- Locations
-
Not specified